(Q67674507)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

1 reference

neoadjuvant chemotherapy

1 reference

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

2 November 2022

author name string

J. Sardi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699851

2 November 2022

C. Sananes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699851

2 November 2022

A. Giaroli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699851

2 November 2022

G. Maya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699851

2 November 2022

G. di Paola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1699851

2 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1699851

2 November 2022

publication date

1 September 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.elsevier.com/content/article/PII:0090825890900964?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

https://api.elsevier.com/content/article/PII:0090825890900964?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

2 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

486-493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children.

16 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

2 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy

2 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx

2 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

The integration of chemotherapy into the management of locally advanced cervical cancer: A pilot study

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

A possible new trend in the management of the carcinoma of the cervix uteri

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri

2 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0090-8258(90)90096-4

2 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1699851%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference